InvestWiser

Magle Chemoswed Holding AB

MAGLENasdaq StockholmHealthcareMarket value 5 m SEK
0.25SEK 0.0%
last day · Price as of 12 November 2026

The answer first

Does Magle Chemoswed Holding beat the market?

No, Magle Chemoswed Holding has not beaten the market over the last year.

Magle Chemoswed Holding−98.7%Stockholm (OMXSGI)+20.8%

Max for seven days

Follow Magle Chemoswed Holding with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 12 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Magle Chemoswed Holding

From today, at a price of 0.25 SEK. Write why you follow Magle Chemoswed Holding, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Magle Chemoswed Holding

Your first answer is free, no account needed.

Do you own Magle Chemoswed Holding, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Magle Chemoswed Holding and a few more. Free, no card.

Past year against the exchange and Super Stock
Magle Chemoswed Holding−98.7%Stockholm (OMXSGI)+20.8%Super Stock+48.4%
11 November 202512 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Magle Chemoswed Holding has fallen 98.7% over the past year, including dividends.
  • The largest fall over the past three years was 99.7%. The price is 99.4% below its peak now.

What do analysts think of Magle Chemoswed Holding?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

Quality–
The company · Fundamentals: the accounts
  • Debt to equityBorrowings divided by equity2.47
  • Asset turnoverSales divided by everything the company owns0.36
  • Return on equityProfit divided by equity−65.2%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value–
The price · Valuation: the multiples
  • P/BPrice divided by equity0.0
  • P/SPrice divided by sales0.0
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend–
The share price · Technical: the price trend
  • 3 months−46.6%
  • 6 months−94.0%
  • 9 months−97.7%
  • 12 months−98.7%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−33.5%
3 years, per year
−78.4%
5 years, per year
−61.4%
Year to date
−98.6%
Largest fall, 3 years
−99.7%
From a peak to the bottom
From the peak now
−99.4%
How far the price is from the peak
Volatility, 1 year
244.7%
How much the price swings over a year
Beta, 1 year
0.62
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Magle Chemoswed Holding

One fund we follow owns Magle Chemoswed Holding. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About Magle Chemoswed Holding

Magle Chemoswed Holding AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Magle Chemoswed Holding is number 123 of 137 companies in healthcare on Nasdaq Stockholm. Magle Chemoswed Holding has not paid a dividend in the past twelve months. The share trades in SEK. It has around 150 employees.

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activities.

See the full analysis of Magle Chemoswed Holding.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market